Lavipharm Sa Stock Revenue
LAVI Stock | EUR 0.85 0.01 1.16% |
Lavipharm SA fundamentals help investors to digest information that contributes to Lavipharm's financial success or failures. It also enables traders to predict the movement of Lavipharm Stock. The fundamental analysis module provides a way to measure Lavipharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lavipharm stock.
Lavipharm |
Lavipharm SA Company Revenue Analysis
Lavipharm's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Lavipharm Revenue | 41.37 M |
Most of Lavipharm's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lavipharm SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Based on the latest financial disclosure, Lavipharm SA reported 41.37 M of revenue. This is 99.46% lower than that of the Healthcare sector and 99.81% lower than that of the Drug Manufacturers - Major industry. The revenue for all Greece stocks is 99.56% higher than that of the company.
Lavipharm Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lavipharm's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lavipharm could also be used in its relative valuation, which is a method of valuing Lavipharm by comparing valuation metrics of similar companies.Lavipharm is currently under evaluation in revenue category among related companies.
Lavipharm Fundamentals
Return On Asset | 0.0403 | |||
Profit Margin | 0.02 % | |||
Operating Margin | 0.08 % | |||
Current Valuation | 59.98 M | |||
Shares Outstanding | 18.29 M | |||
Shares Owned By Insiders | 67.47 % | |||
Price To Earning | 12.42 X | |||
Price To Sales | 0.17 X | |||
Revenue | 41.37 M | |||
Gross Profit | 15.89 M | |||
EBITDA | 4.72 M | |||
Net Income | 1.72 M | |||
Cash And Equivalents | 1.85 M | |||
Cash Per Share | 0.04 X | |||
Total Debt | 40.54 M | |||
Current Ratio | 1.29 X | |||
Book Value Per Share | (0.47) X | |||
Cash Flow From Operations | 3.82 M | |||
Earnings Per Share | 0.04 X | |||
Beta | 0.66 | |||
Market Capitalization | 8.56 M | |||
Total Asset | 82 M | |||
Retained Earnings | (181 M) | |||
Working Capital | (66 M) | |||
Current Asset | 21 M | |||
Current Liabilities | 87 M | |||
Z Score | -2.8 | |||
Five Year Return | 4.13 % |
About Lavipharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lavipharm SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lavipharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lavipharm SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lavipharm in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lavipharm's short interest history, or implied volatility extrapolated from Lavipharm options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lavipharm SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Lavipharm Stock analysis
When running Lavipharm's price analysis, check to measure Lavipharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lavipharm is operating at the current time. Most of Lavipharm's value examination focuses on studying past and present price action to predict the probability of Lavipharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lavipharm's price. Additionally, you may evaluate how the addition of Lavipharm to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |